Impact of open-label versus blinded study design on patient-reported outcomes data in randomized clinical trials of immunotherapy in advanced or metastatic cancer patients: a systematic review

被引：0
|
作者：
Amélie Anota
Astrid Pozet
Hervé Lemasson
Francois-Emery Cotté
Antoine Falcoz
Guillaume Eberst
Guillaume Mouillet
Stéphane Guerzider
Émilie Charton
Virginie Westeel
机构：
[1] University Hospital of Besançon,Methodology and Quality of Life Unit in Oncology (INSERM UMR 1098)
[2] French National Platform Quality of Life and Cancer,Chest Disease Department
[3] Bristol-Myers Squibb,undefined
[4] University Hospital of Besançon,undefined
来源：
Quality of Life Research | 2022年 / 31卷
关键词：
Bias; Immuno-oncology; Open label; Patient-reported outcomes; Quality of life; Randomized controlled trials;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：645 / 657
页数：12
相关论文
共 50 条
  • [21] Multicenter, open-label, randomized, controlled study to test the utility of electronic patient-reported outcome monitoring in patients with unresectable advanced cancers or metastatic/recurrent solid tumors
    Taira, Naruto
    Kiyota, Naomi
    Kikawa, Yuichiro
    Ichihara, Eiki
    Kato, Kyoko
    Kubota, Kaoru
    Tateishi, Ryosuke
    Nakata, Akinobu
    Nakamura, Keiichiro
    Narita, Yukiya
    Hotta, Katsuyuki
    Iwata, Hiroji
    Gemma, Akihiko
    Shimozuma, Kojiro
    Muro, Kei
    Iwamoto, Tetsuya
    Takumoto, Yuki
    Shiroiwa, Takeru
    Fukuda, Takashi
    Yamaguchi, Takuhiro
    Hagiwara, Yasuhiro
    Minami, Hironobu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2025, : 547 - 555
  • [22] A systematic review on patient-reported outcomes in cancer survivors of randomised clinical trials: direction for future research
    Li, Qiuping
    Lin, Yi
    Liu, Xiwen
    Xu, Yongyong
    PSYCHO-ONCOLOGY, 2014, 23 (07) : 721 - 730
  • [23] Past and Current Practice of Patient-Reported Outcome Measurement in Randomized Cancer Clinical Trials: A Systematic Review
    Giesinger, Johannes M.
    Efficace, Fabio
    Aaronson, Neil
    Calvert, Melanie
    Kyte, Derek
    Cottone, Francesco
    Cella, David
    Gamper, Eva-Maria
    VALUE IN HEALTH, 2021, 24 (04) : 585 - 591
  • [24] 15 years of patient-reported outcomes in clinical trials leading to GU cancer drug approvals: a systematic review on the quality of data reporting and analysis
    Paravathaneni, Mahati
    Safa, Houssein
    Joshi, Vidhu
    Tamil, Monica K.
    Adashek, Jacob J.
    Ionescu, Filip
    Shah, Savan
    Chadha, Juskaran S.
    Gilbert, Scott
    Manley, Brandon
    Semaan, Adele
    Jim, Heather S. L.
    Kalos, Denise
    Kim, Youngchul
    Spiess, Philippe E.
    Chahoud, Jad
    ECLINICALMEDICINE, 2024, 68
  • [25] Reporting of patient-reported outcomes amongst randomized clinical trials in plastic surgery: a systematic review using CONSORT-PRO
    Milazzo, Thomas
    Yuan, Morgan
    Graham, Amy
    Kim, Patrick
    Gallo, Lucas
    Uhlman, Kathryn
    Thoma, Achilleas
    Coroneos, Christopher
    Voineskos, Sophocles
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2024, 99 : 110 - 121
  • [26] Interdisciplinary interventions that improve patient-reported outcomes in perioperative cancer care: A systematic review of randomized control trials
    Maheta, Bhagvat J.
    Singh, Nainwant K.
    Lorenz, Karl A.
    Fereydooni, Sarina
    Dy, Sydney M.
    Wong, Hong-nei
    Bergman, Jonathan
    Leppert, John T.
    Giannitrapani, Karleen F.
    PLOS ONE, 2023, 18 (11):
  • [27] Association of Anticancer Immune Checkpoint Inhibitors With Patient-Reported Outcomes Assessed in Randomized Clinical Trials A Systematic Review and Meta-analysis
    Pala, Laura
    Sala, Isabella
    Oriecuia, Chiara
    De Pas, Tommaso
    Queirolo, Paola
    Specchia, Claudia
    Cocorocchio, Emilia
    Ferrucci, Pierfrancesco
    Patane, Damiano
    Saponara, Maristella
    Pennacchioli, Elisabetta
    Coppola, Sara
    Viale, Giuseppe
    Giaccone, Giuseppe
    Gelber, Richard D.
    Bagnardi, Vincenzo
    Conforti, Fabio
    JAMA NETWORK OPEN, 2022, 5 (08) : e2226252
  • [28] Patient-Reported Outcomes From Patients Receiving Immunotherapy or Chemoimmunotherapy for Metastatic Non-Small-Cell Lung Cancer in Clinical Practice
    McLouth, Laurie E. Steffen
    Lycan, Thomas W., Jr.
    Levine, Beverly J.
    Gabbard, Jennifer
    Ruiz, Jimmy
    Farris, Michael
    Grant, Stefan C.
    Pajewski, Nicholas M.
    Weaver, Kathryn E.
    Petty, W. Jeffrey
    CLINICAL LUNG CANCER, 2020, 21 (03) : 255 - +
  • [29] Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer A Randomized Clinical Trial
    Basch, Ethan
    Schrag, Deborah
    Henson, Sydney
    Jansen, Jennifer
    Ginos, Brenda
    Stover, Angela M.
    Carr, Philip
    Spears, Patricia A.
    Jonsson, Mattias
    Deal, Allison M.
    Bennett, Antonia, V
    Thanarajasingam, Gita
    Rogak, Lauren J.
    Reeve, Bryce B.
    Snyder, Claire
    Bruner, Deborah
    Cella, David
    Kottschade, Lisa A.
    Perlmutter, Jane
    Geoghegan, Cindy
    Samuel-Ryals, Cleo A.
    Given, Barbara
    Mazza, Gina L.
    Miller, Robert
    Strasser, Jon F.
    Zylla, Dylan M.
    Weiss, Anna
    Blinder, Victoria S.
    Dueck, Amylou C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (24): : 2413 - 2422
  • [30] Impact of enzalutamide on patient-reported fatigue in patients with prostate cancer: data from the pivotal clinical trials
    Tombal, Bertrand F.
    Freedland, Stephen J.
    Armstrong, Andrew J.
    Beer, Tomasz M.
    Stenzl, Arnulf
    Sternberg, Cora N.
    Hussain, Maha
    Ganguli, Arijit
    Ramaswamy, Krishnan
    Bhadauria, Hemant
    Ivanescu, Cristina
    Turnbull, James
    Holmstrom, Stefan
    Saad, Fred
    PROSTATE CANCER AND PROSTATIC DISEASES, 2022, 25 (02) : 288 - 295
12345